Literature DB >> 12153575

NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains.

K Wecker1, N Morellet, S Bouaziz, B P Roques.   

Abstract

The human immunodeficiency virus type 1, HIV-1, genome encodes a highly conserved regulatory gene product, Vpr (96 amino acids), which is incorporated into virions in quantities equivalent to those of the viral Gag protein. In infected cells, Vpr is believed to function during the early stages of HIV-1 replication (such as transcription of the proviral genome and migration of preintegration nuclear complex), blocks cells in G2 phase and triggers apoptosis. Vpr also plays a critical role in long-term AIDS disease by inducing viral infection in nondividing cells such as monocytes and macrophages. To gain deeper insight of the structure-function relationship of Vpr, the intact protein (residues 1-96) was synthesized. Its three-dimensional structure was analysed using circular dichroism and two-dimensional 1H- and 15N-NMR and refined by restrained molecular dynamics. In addition, 15N relaxation parameters (T1, T2) and heteronuclear 1H-15N NOEs were measured. The structure of the protein is characterized by a well-defined gamma turn(14-16)-alpha helix(17-33)-turn(34-36), followed by a alpha helix(40-48)-loop(49-54)-alpha helix(55-83) domain and ends with a very flexible C-terminal sequence. This structural determination of the whole intact Vpr molecule provide insights into the biological role played by this protein during the virus life cycle, as such amphipathic helices are believed to be involved in protein-lipid bilayers, protein-protein and/or protein-nucleic acid interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153575     DOI: 10.1046/j.1432-1033.2002.03067.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  22 in total

Review 1.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

Review 2.  Defining the roles for Vpr in HIV-1-associated neuropathogenesis.

Authors:  Tony James; Michael R Nonnemacher; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-04-07       Impact factor: 2.643

3.  Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.

Authors:  Maoyi Lai; Erik S Zimmerman; Vicente Planelles; Junjie Chen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Creating a community resource for protein science.

Authors:  Helen M Berman
Journal:  Protein Sci       Date:  2012-09-28       Impact factor: 6.725

Review 5.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

6.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Authors:  Sarah Bourbigot; Hervé Beltz; Jérôme Denis; Nelly Morellet; Bernard P Roques; Yves Mély; Serge Bouaziz
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

7.  The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

Authors:  Julien Bischerour; Patrick Tauc; Hervé Leh; Hugues de Rocquigny; Bernard Roques; Jean-François Mouscadet
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

8.  The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.

Authors:  Sara M Solbak; Tove R Reksten; Victor Wray; Karsten Bruns; Ole Horvli; Arnt J Raae; Petra Henklein; Peter Henklein; Rene Röder; David Mitzner; Ulrich Schubert; Torgils Fossen
Journal:  BMC Struct Biol       Date:  2010-10-04

9.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

10.  Modulating the activity of the channel-forming segment of Vpr protein from HIV-1.

Authors:  Chin-Pei Chen; Clemens Kremer; Peter Henklein; Ulrich Schubert; Rainer H A Fink; Wolfgang B Fischer
Journal:  Eur Biophys J       Date:  2009-07-24       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.